Microsoft published a list of everything wrong with its own defaults.

Experimental feature allows users to get a second opinion from a complementary model on the primary agent’s work.

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...